NASDAQ:TXG 10x Genomics - TXG News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $49.04 +0.28 (+0.57%) (As of 03/23/2023 12:00 AM ET) Add Compare Share Share Today's Range$48.60▼$51.5550-Day Range$43.22▼$51.6152-Week Range$23.81▼$83.34Volume707,566 shsAverage Volume1.06 million shsMarket Capitalization$5.66 billionP/E RatioN/ADividend YieldN/APrice Target$52.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address TXG Media Mentions By Week TXG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼1.030.35▲Average Medical News Sentiment TXG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼32▲TXG Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAllworth Financial LP Has $1.88 Million Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)marketbeat.com - March 23 at 5:51 AM10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Hold" from Analystsmarketbeat.com - March 22 at 2:20 AMWe're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wiselyfinance.yahoo.com - March 2 at 8:11 AM10x Genomics to Present at the 43rd Annual Cowen Healthcare Conferencefinance.yahoo.com - February 22 at 5:59 PM10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - February 16 at 8:15 PMMorgan Stanley Reaffirms Their Buy Rating on 10x Genomics (TXG)markets.businessinsider.com - February 16 at 7:42 AM10x Genomics, Inc.: 10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023finanznachrichten.de - February 16 at 5:12 AM10x Genomics GAAP EPS of -$0.15 beats by $0.17, revenue of $156.2M beats by $8.03Mmsn.com - February 15 at 4:39 PM10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023finance.yahoo.com - February 15 at 4:39 PM10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meetingfinance.yahoo.com - February 6 at 10:42 AMTXG.O - | Stock Price & Latest News | Reutersreuters.com - January 26 at 8:50 PM10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023finance.yahoo.com - January 19 at 7:01 PM10x Genomics toolkit ‘at the fulcrum of innovation,’ CEO saysfinance.yahoo.com - January 10 at 12:15 PM10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 28 at 6:13 PM10x Genomics: Long-Term Growth Potential Marred By Near-Term Funding Risksseekingalpha.com - December 27 at 10:27 PM10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%finance.yahoo.com - December 22 at 8:19 AM10x Genomics Earnings Perspective: Return On Capital Employedmsn.com - December 19 at 1:45 PM10x Genomics Commercially Launches Xenium Platform for In Situ Analysisfinance.yahoo.com - December 8 at 5:16 PMEast Bay startup Infinimmune's secret for building better antibody drugs: Youbizjournals.com - December 6 at 6:20 PMAt US$38.66, Is It Time To Put 10x Genomics, Inc. (NASDAQ:TXG) On Your Watch List?finance.yahoo.com - December 1 at 6:59 AM10x Genomics's Return On Capital Employed Insightsmsn.com - November 16 at 4:30 PM10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discoveryfinance.yahoo.com - November 9 at 6:21 PM10x Genomics Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 9 at 8:20 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS), Avanos Medical (AVNS) and 10x Genomics (TXG)markets.businessinsider.com - November 7 at 11:53 PMHere’s Why 10x Genomics (TXG) Underperformed in the Third Quarterfinance.yahoo.com - November 4 at 10:57 PM10x Genomics, Inc.'s (NASDAQ:TXG) Intrinsic Value Is Potentially 99% Above Its Share Pricefinance.yahoo.com - November 4 at 12:55 PM10x Genomics, Inc. (TXG) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 3 at 12:23 AM10x Genomics Reports Third Quarter 2022 Financial Resultsmarkets.businessinsider.com - November 2 at 7:22 PM10x Genomics to Host Investor Day on December 8, 2022finance.yahoo.com - November 1 at 12:21 AMPacBio's (PACB) Latest Offering to Enhance Disease Discoveriesfinance.yahoo.com - October 24 at 12:02 PMPacific Biosciences' Tools Expansion Doesn't Guarantee Successfinance.yahoo.com - October 24 at 12:02 PM10x Genomics to Report Third Quarter Financial Results on November 2, 2022finance.yahoo.com - October 12 at 4:12 PMA Strong Dollar Could Whack These Biotech Stocksfinance.yahoo.com - October 3 at 10:19 PM10x Genomics (NASDAQ:TXG) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - September 23 at 7:58 AM10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conferencefinance.yahoo.com - September 2 at 5:23 PM10x Genomics cut to Sell at Goldman Sachs on slower sales rampseekingalpha.com - August 19 at 7:32 PM10x Genomics Offerings Not Yet Big Enough to Offset Core Business Deceleration - GSinvesting.com - August 18 at 6:24 PMPremarket Movers: Wolfspeed, XP, 10x Genomicsbarrons.com - August 18 at 8:21 AMWhat Kind Of Shareholders Hold The Majority In 10x Genomics, Inc.'s (NASDAQ:TXG) Shares?finance.yahoo.com - August 13 at 12:38 PM10x Genomics Return On Capital Employed Overviewmsn.com - August 12 at 11:28 AMWhat 4 Analyst Ratings Have To Say About 10x Genomicsmarkets.businessinsider.com - August 10 at 3:42 PM10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 8 at 9:35 PMLayoffs hit East Bay biotech research tools company as it aims to become more 'resilient'bizjournals.com - August 8 at 5:55 PM10x Genomics Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 8 at 4:35 PMAnalysts Estimate 10x Genomics (TXG) to Report a Decline in Earnings: What to Look Out forfinance.yahoo.com - August 1 at 1:40 PM10x Genomics: Still Expensive, No Profitability In Sight, And Insiders Are Still Sellingseekingalpha.com - July 30 at 7:47 AM10x Genomics Stock Rebound Depends on Growthfinance.yahoo.com - July 29 at 7:31 PMCytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investmentsseekingalpha.com - July 29 at 4:28 AM10x Genomics (NASDAQ:TXG) investors are sitting on a loss of 80% if they invested a year agonasdaq.com - July 29 at 4:28 AM10X Genomics’ Stock Got Crushed. Here’s Why.finance.yahoo.com - July 15 at 8:31 PM10x Genomics stock suffering record drop toward record low after revenue warnings prompts downgradefinance.yahoo.com - July 15 at 11:17 AMPremarket Movers: 10x Genomics, Pinterest, National Retail Prpertiesbarrons.com - July 15 at 10:31 AM Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:TXG) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.